King & Wood Mallesons SJ Berwin advised Capzanine on the unitranche financing of the acquisition of Asdia by AMS from the CeeD (Centre Européen d’Etude du Diabète), as well as on the refinancing of the debt of AMS.

To finance this build-up, AMS reviewed the financing of its LBO, initally based on a senior and mezzanine debt, chosing an unitranche loan provided by Capzanine.

Capzanine, which carried-out the buyout of AMS in 2008 and is now a minority shareholder, is an independent investment fund and a pioneer in combined equity and mezzanine investment. It supports businesses in their quest for growth.

Predominantly owned by LBO Partners since 2011, AMS is a provider of home healthcare services, specialising in medical equipment specific to respiratory illnesses, insulin therapy and perfusion.

Headquartered in Strasbourg and created 12 years ago by the CeeD, Asdia specialises in medical-technical home services in the field of insulin therapy and CPAP (continuous positive airway pressure) respiratory support.

The King & Wood Mallesons SJ Berwin team was composed of Finance partner Olivier Vermeulen and associates Marc Zérah and Margaux Barrate; as well as of Tax partner Raphael Bera.